1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
2026 Title III: Freeborn County – Special Older Americans Act Fund is a grant from Southeastern Minnesota Area Agency on Aging (SEMAAA) that funds direct support services for adults aged 60 and older in Freeborn County, Minnesota. The program solicits proposals under Older Americans Act Title III-B (supportive services) and III-E (caregiver support) for services beginning as early as January 1, 2026.
Eligible applicants include nonprofit and for-profit agencies providing services directly to older adults and their caregivers; joint applications and subcontracts are not accepted. Interested organizations were required to submit a letter of intent by November 19, 2025. Award amounts vary based on proposed services.
The grant is administered through a competitive application process.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official RFP to help you evaluate fit faster.
2026 Title III: Freeborn County – Special Older Americans Act Fund Availability Announcement Skip to primary navigation 2026 Title III: Freeborn County Special Older Americans Act Fund Availability Announcement Southeastern Minnesota Area Agency on Aging (SEMAAA) 2746 Superior Drive NW, Suite 300 Anna Thomson, OAA Grants Manager Deadline to submit applicant interest and intent: Pre-application Q&A and technical assistance period: Application period opens: Last day to submit questions: December 4, 2025, at 4:00pm Applicants informed of award decisions: Services begin (as early as): SEMAAA invites proposals for Older Americans Act (OAA) III-B and III-E services for delivery to begin as early as January 1, 2026, in Freeborn County.
This special 2026 Request for Proposal is an open invitation to nonprofits and for-profit agencies (with special approval by SEMAAA and the Minnesota Board on Aging) for the purpose of providing support services to people 60 years of age and older in Freeborn County. The following proposals will not be accepted: joint applications, applications that include subcontracts, and applications submitted by individuals.
Please note that this is a competitive grant round. Interested parties should submit interest and intended programs in writing to anna@semaaa. org before November 19, 2025, to begin the pre-application process and receive an invitation to the appropriate application(s).
For the full details, please download the announcement. 2026 Title III: Freeborn County Special Older Americans Act Fund Availability Announcement Announcement: MN Aging Pathways UPCOMING CLASSES & EVENTS 2746 Superior Drive NW, Ste. 300 Southeastern Minnesota Area Agency on Aging, Inc. Healthy Aging – Health Promotion Programs
According to the current listing, eligibility includes: Agencies and organizations providing direct services to older adults and caregivers in Freeborn County, Minnesota. Confirm the full requirements in the official notice before applying.
2026 Title III: Freeborn County – Special Older Americans Act Fund is funded by Southeastern Minnesota Area Agency on Aging (SEMAAA). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Minnesota. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The new ENRTF Community Grant Program offers $20,000 to $150,000 with no match and a short concept note first. How the two stages score, and who has the edge.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article